2-(4-Indan-1-onyl)-essigsaeure | 103989-64-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 2-(4-Indan-1-onyl)-essigsaeure
• 英文别名: (1-oxo-indan-4-yl)acetic acid；4-carboxymethylindanone；(1-oxoindan-4-yl)acetic acid；1-Oxo-4-indanessigsaeure；2-(1-oxo-2,3-dihydroinden-4-yl)acetic acid
• CAS: 103989-64-6
• 化学式: C₁₁H₁₀O₃
• mdl: MFCD18647912
• 分子量: 190.199
• InChiKey: BMKBHIHOFMEHGY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.272
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(4-Indan-1-onyl)-essigsaeure 在 18-冠醚-6 、 溴 、 potassium carbonate 、 N,N'-羰基二咪唑 作用下， 以 四氢呋喃 、 二氯甲烷 、 丙酮 为溶剂， 反应 2.0h， 生成 ethyl 1-[4-(N-methylaminocarbonylmethyl)-1-oxoindan-2-yl]imidazole-2,4-dicarboxylate
  参考文献：
  名称：

  Bioisosteres of 9-Carboxymethyl-4-oxo-imidazo[1,2- a ]indeno[1,2- e ]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent In Vivo AMPA antagonists with longer durations of action

  摘要：

  A novel series of 2- and 9-disubstituted heterocyclic-fused 4-oxo-indeno[1,2-e]pyrazin derivatives was synthesized. One of them, the 9-(1 H-tetrazol-5-ylmethyl)-4-oxo-5,10-dihydroimidazo[1,2-a]indeno[1,2-e]pyrazin-2-yl phosphonic acid 4i exhibited a strong and a selective binding affinity for the AMPA receptor (IC50 = 13 nM) and demonstrated potent antagonist activity (IC50 = 6 nM) at the ionotropic AMPA receptor. This compound also displayed good anticonvulsant properties against electrically-induced convulsions after ip and iv administration with ED50 values between 0.8 and 1 mg/kg. Furthermore, a strong increase in potency was observed when given iv 3 h before test (ED50 = 3.5 instead of 25.6 mg/kg for the corresponding 9-carboxymethyl-2-carboxylic acid analogue). These data confirmed that there is an advantage in replacing the classical carboxy substituents by their bioisosteres such as tetrazole or phosphonic acid groups. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00592-8
• 作为产物：
  描述：

  3-[2-(羧甲基)苯基]丙酸 以 硫酸 为溶剂， 生成 2-(4-Indan-1-onyl)-essigsaeure
  参考文献：
  名称：

  5H,10H-imidazo\x9b1,2-a!indeno\x9b1,2-e!pyrazin-4-one derivatives, preparation

  摘要：

  式(I)化合物，其中R为氢原子或羧基、烷氧羰基、--CO--NR₄R₅、--PO₃H₂或--CH₂OH基团，R₁为-烷基-NH₂、-烷基-NH--CO--R₃、-烷基-COOR₄、-烷基-CO--NR₅R₆或--CO--NH--R₇基团。式(I)化合物具有宝贵的药理特性，是α-氨基-3-羟基-5-甲基-4-异噁唑丙酸(AMPA)受体即quisqualate受体的拮抗剂。此外，式(I)化合物是非竞争性N-甲基-D-天冬氨酸(NMDA)受体的拮抗剂，更具体地说是NMDA受体甘氨酸调节位点的配体。

  公开号：

  US05902803A1

文献信息

• 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives,
  申请人：Rhone Poulenc Rorer S.A.

  公开号：US05990108A1

  公开（公告）日：1999-11-23

  Compounds of formula (I), wherein R is a hydrogen atom or a --COOH, -alk-COOH, --PO.sub.3 H.sub.2, --CH.sub.2 --PO.sub.3 H.sub.2, or --CH.dbd.CH--COOH radical, or a phenyl radical substituted by a carboxy radical, R.sub.1 is an alk-CN, -alk-COOH, -alk-Het, alk-PO.sub.3 H.sub.2 or -alk-CO--NH--SO.sub.2 R.sub.2 radical, R.sub.2 is an alkyl or phenyl radical, alk is an alkyl radical, Het is a saturated or unsaturated mono- or polycyclic heterocyclic ring containing 1-9 carbon atoms and one or more heteroatoms selected from O, S and N, said heterocyclic ring optionally being substituted by one or more alkyl, phenyl or phenylalkyl radicals, with the proviso that when R is a hydrogen atom or a --COOH or --PO.sub.3 H.sub.2 radical, R.sub.1 cannot be -alk-COOH, isomers, racemic mixtures, enantiomers and diastereoisomers thereof, salts thereof, the preparation thereof, intermediates thereof and drugs containing said compounds, are disclosed. The compounds of formula (I) have valuable pharmacological properties and are antagonists of the .alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor also known as the quisqualate receptor. Furthermore, the compounds of formula (I) are non-competitive antagonists of the N-methyl-D-aspartate (NMDA) receptor, and specifically ligands for NMDA receptor glycine modulator sites. ##STR1##

  化合物的化学式（I），其中R是氢原子或--COOH，-烷基-COOH，--PO.sub.3 H.sub.2，--CH.sub.2 --PO.sub.3 H.sub.2或--CH.dbd.CH--COOH基团，或被羧基取代的苯基基团，R.sub.1是烷基-CN，-烷基-COOH，-烷基-Het，烷基-PO.sub.3 H.sub.2或-烷基-CO--NH--SO.sub.2 R.sub.2基团，R.sub.2是烷基或苯基基团，烷基是烷基基团，Het是含有1-9个碳原子和一个或多个异原子（O、S和N）的饱和或不饱和单环或多环杂环环，该杂环环可以选择性地被一个或多个烷基，苯基或苯基烷基基团取代，但是当R是氢原子或--COOH或--PO.sub.3 H.sub.2基团时，R.sub.1不能是-烷基-COOH，其同分异构体，消旋混合物，对映异构体和非对映异构体，以及其盐，其制备方法，其中间体和含有该化合物的药物已被披露。化合物的化学式（I）具有有价值的药理学性质，并且是α-氨基-3-羟基-5-甲基-4-异恶唑丙酸（AMPA）受体的拮抗剂，也被称为quisqualate受体。此外，化合物的化学式（I）是N-甲基-D-天冬氨酸（NMDA）受体的非竞争性拮抗剂，特别是NMDA受体甘氨酸调节剂位点的配体。
• 9-Carboxymethyl-5 H ,10 H -imidazo[1,2- a ]indeno[1,2- e ]pyrazin-4-one-2-carbocylic Acid (RPR117824): Selective Anticonvulsive and Neuroprotective AMPA Antagonist
  作者：Serge Mignani、Georg Andrees Bohme、Guillaume Birraux、Alain Boireau、Patrick Jimonet、Dominique Damour、Arielle Genevois-Borella、Marc-Williams Debono、Jeremy Pratt、Marc Vuilhorgne、Florence Wahl、Jean-Marie Stutzmann

  DOI：10.1016/s0968-0896(01)00431-x

  日期：2002.5

  antagonists may have broad therapeutic potential in neurology. Here, we describe the synthesis, pharmacological properties and neuroprotective activity of 9-carboxymethyl-imidazo-[1-2a]indeno[1-2e]pyrazin-4-one-2-carboxylic acid (RPR117824), an original selective AMPA antagonist. RPR117824 can be obtained through a six-step synthesis starting from (1-oxo-indan-4-yl) acetic acid, which has been validated on a

  谷氨酸（一种有效的兴奋性神经递质）的过量释放被认为在多种急慢性神经系统疾病中起重要作用，这表明兴奋性氨基酸拮抗剂在神经病学中可能具有广泛的治疗潜力。在这里，我们描述了原始的选择性AMPA拮抗剂9-羧甲基-咪唑并[1-2a]茚并[1-2e]吡嗪-4-酮-2-羧酸（RPR117824）的合成，药理性质和神经保护活性。RPR117824可以通过从（1-氧代-茚满-4-基）乙酸开始的六步合成获得，该合成已以克为单位进行了验证，总收率为25％。该化合物的一钠盐或二钠盐在盐水中的溶解性极佳（>或= 10 g / L），可以静脉内给药。RPR117824对AMPA受体表现出纳摩尔亲和力（IC（50）= 18 nM），并且竞争抑制非洲爪蟾卵母细胞（K（B）= 5 nM）和大鼠脑切片中的天然受体异源表达的AMPA受体介导的电生理反应。 50）= 0.36 microM）。在体内测试中，RPR117824可作
• Canton, Thierry; Boehme, Georg Andrees; Boireau, Alain, Journal of Pharmacology and Experimental Therapeutics, 2001, vol. 299, # 1, p. 314 - 322
  作者：Canton, Thierry、Boehme, Georg Andrees、Boireau, Alain、Bordier, Francoise、Mignani, Serge、Jimonet, Patrick、Jahn, Ghafoor、Alavijeh, Mohammad、Stygall, James、Roberts, Simon、Brealey, Clive、Vuilhorgne, Marc、Debono, Marc-William、Le Guern, Sylvain、Laville, Michel、Briet, Dominique、Roux, Michel、Stutzmann, Jean-Marie、Pratt, Jeremy

  DOI：——

  日期：——
• Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid AMPA antagonists
  作者：Jeremy Pratt、Patrick Jimonet、Georg Andrees Bohme、Alain Boireau、Dominique Damour、Marc Williams Debono、Arielle Genevois-Borella、John C.R Randle、Yves Ribeill、Jean-Marie Stutzmann、Marc Vuilhorgne、Serge Mignani

  DOI：10.1016/s0960-894x(00)00561-8

  日期：2000.12

  The over-stimulation of excitatory amino acid receptors such as the glutamate AMPA receptor has been suggested to be associated with neurodegenerative disorders. Here we describe an original series of readily water soluble 4-oxo-imidazo[1,2-a] indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid derivatives. One of these compounds, 4f, exhibited nanomolar binding affinity, potent competitive antagonism at the ionotropic AMPA receptor and a long duration of anticonvulsant activity after administration by parenteral route in vivo. (C) 2000 Elsevier Science Ltd. All rights reserved.
• Aromatische Spirane, 22. Mitt.: Darstellung von Cyclopenteno-4,5-indan-1-on und 2-Carboxymethyl-bzw. 4-Chlormethyl-indan als Synthone f�r Synthesen von anellierten 2,2?-Spirobiindanonen
  作者：M. Melmer、H. Neudeck

  DOI：10.1007/bf00813793

  日期：1996.3

  The title compounds were prepared as follows: tert.-butyl-indane (10) was formylated to give a 72:28 mixture of the aldehydes 23a and 23b which were submitted to a Knoevenagel-Doebner condensation to afford the cinnamonic acids 24. From the mixture, the pure stereoisomer 24a was obtained by one crystallization in 57% yield. Its methylester 27a could be quantitatively dealkylated to the methylester 8 by treatment with AlCl3 in toluene. Cyclization to the indanone 9 was then performed via the propionic acid 7 with polyphosphoric acid in 95% yield. From 9 the carboxymethyl derivative 30 was obtained by treatment with dimethylcarbonate and NaH. The second synthone 4-chlormethylindane (19) was prepared from the corresponding alcohol 18 (in 82% yield) which in turn could be obtained from methylester 17 by reduction with LiAlH4. The latter was accessible in 75% yield by dealkylation of ester 13.